A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats

BACKGROUND: Oclacitinib is a Janus kinase (JAK) 1 enzyme inhibitor and blocks JAK1-dependent cytokines and is used to control pruritus. Studies available in cats are very limited and as there is a potential role for oclacitinib in the control of pruritus in this specie, the aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Natália Lôres, Campos, Diefrey Ribeiro, Machado, Marília Alves, Alves, Mariana Silva Revoredo, de Souza, Manuela Silva Gomes, da Veiga, Cristiano Chaves Pessoa, Merlo, Alexandre, Scott, Fábio Barbour, Fernandes, Julio Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506962/
https://www.ncbi.nlm.nih.gov/pubmed/31068210
http://dx.doi.org/10.1186/s12917-019-1893-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506962/
https://www.ncbi.nlm.nih.gov/pubmed/31068210
http://dx.doi.org/10.1186/s12917-019-1893-x

Ejemplares similares